|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sher DJ, Fidler MJ, Liptay MJ and Koshy M:
Comparative effectiveness of neoadjuvant chemoradiotherapy versus
chemotherapy alone followed by surgery for patients with stage IIIA
non-small cell lung cancer. Lung Cancer. 88:267–274. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moran C: Importance of molecular features
of non-small cell lung cancer for choice of treatment. Am J Pathol.
178:1940–1948. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelialmesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iwatsuki M, Mimori K, Yokobori T, Ishi H,
Beppu T, Nakamori S, Baba H and Mori M: Epithelial-mesenchymal
transition in cancer development and its clinical significance.
Cancer Sci. 101:293–299. 2010. View Article : Google Scholar
|
|
8
|
Chen A, Beetham H, Black MA, Priya R,
Telford BJ, Guest J, Wiggins GA, Godwin TD, Yap AS and Guilford PJ:
E-cadherin loss alters cytoskeletal organization and adhesion in
non-malignant breast cells but is insufficient to induce an
epithelial-mesenchymal transition. BMC Cancer. 14:5522014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
de Herreros AG, Peiro S, Nassour M and
Savagner P: Snail family regulation and epithelial mesenchymal
transitions in breast cancer progression. J Mammary Gland Biol
Neoplasia. 15:135–147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Come C, Magnino F, Bibeau F, De Santa
Barbara P, Becker KF, Theillet C and Savagner P: Snail and slug
play distinct roles during breast carcinoma progression. Clin
Cancer Res. 12:5395–5402. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kroepil F, Fluegen G, Vallböhmer D, Baldus
SE, Dizdar L, Raffel AM, Hafner D, Stoecklein NH and Knoefel WT:
Snaill expression in colorectal cancer and its correlation with
clinical and pathological parameters. BMC Cancer. 13:1452013.
View Article : Google Scholar
|
|
13
|
Cheon MG, Kim W, Choi M and Kim JE: AK-1,
a specific SIRT2 inhibitor, induces cell cycle arrest by
downregulating Snail in HCT116 human colon carcinoma cells. Cancer
Lett. 356B:637–645. 2015. View Article : Google Scholar
|
|
14
|
Vega S, Morales AV, Ocana OH, Valdés F,
Fabregat I and Nieto MA: Snail blocks the cell cycle and confers
resistance to cell death. Genes Dev. 18:1131–1143. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lan L, Han H, Zuo H, Chen Z, Du Y, Zhao W,
Gu J and Zhang Z: Upregulation of myosin Va by Snail is involved in
cancer cell migration and metastasis. Int J Cancer. 126:53–64.
2010. View Article : Google Scholar
|
|
16
|
Xiao W, Chen X, Liu X, Luo L, Ye S and Liu
Y: Trichostatin A, a histone deacetylase inhibitor, suppresses
proliferation and epithelial-mesenchymal transition in retinal
pigment epithelium cells. J Cell Mol Med. 18:646–655. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su B, Zhao W, Shi B, Zhang Z, Yu X, Xie F,
Guo Z, Zhang X, Liu J, Shen Q, et al: Let-7d suppresses growth,
metastasis, and tumor macrophage infiltration in renal cell
carcinoma by targeting COL3A1 and CCL7. Mol Cancer. 13:2062014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zijlstra A, Mellor R, Panzarella G, Aimes
RT, Hooper JD, Marchenko ND and Quigley JP: A quantitative analysis
of rate- limiting steps in the metastatic cascade using
human-specific real-time polymerase chain reaction. Cancer Res.
62:7083–7092. 2002.PubMed/NCBI
|
|
19
|
Yuen HF, Chan YK, Grills C, McCrudden CM,
Gunasekharan V, Shi Z, Wong AS, Lappin TR, Chan KW, Fennell DA, et
al: Polyomavirus enhancer activator 3 protein promotes breast
cancer metastatic progression through Snail-induced
epithelialmesenchymal transition. J Pathol. 224:78–89. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Talbot LJ, Bhattacharya SD and Kuo PC:
Epithelial-mesenchymal transition, the tumor microenvironment, and
metastatic behavior of epithelial malignancies. Int J Biochem Mol
Biol. 3:117–136. 2012.PubMed/NCBI
|
|
21
|
Shin NR, Jeong EH, Choi CI, Moon HJ, Kwon
CH, Chu IS, Kim GH, Jeon TY, Kim DH, Lee JH, et al: Overexpression
of Snail is associated with lymph node metastasis and poor
prognosis in patients with gastric cancer. BMC Cancer. 12:5212012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kuo KT, Chou TY, Hsu HS, Chen WL and Wang
LS: Prognostic significance of NBS1 and Snail expression in
esophageal squamous cell carcinoma. Ann Surg Oncol. 19(Suppl 3):
S549–S557. 2012. View Article : Google Scholar
|
|
23
|
Hotz B, Arndt M, Dullat S, Bhargava S,
Buhr HJ and Hotz HG: Epithelial to mesenchymal transition:
Expression of the regulators snail, slug, and twist in pancreatic
cancer. Clin Cancer Res. 13:4769–4776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van Nes JG, de Kruijf EM, Putter H,
Faratian D, Munro A, Campbell F, Smit VT, Liefers GJ, Kuppen PJ,
van de Velde CJ, et al: Co-expression of SNAIL and TWIST determines
prognosis in estrogen receptor-positive early breast cancer
patients. Breast Cancer Res Treat. 133:49–59. 2012. View Article : Google Scholar
|
|
25
|
Kobayashi M, Huang CL, Sonobe M, Kikuchi
R, Ishikawa M, Imamura N, Kitamura J, Iwakiri S, Itoi K, Yasumizu
R, et al: Snail expression is associated with a poor prognosis in
malignant pleural mesotheliomas. Ann Thorac Surg. 95:1181–1188.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yasui K, Shimamura M, Mitsutake N and
Nagayama Y: SNAIL induces epithelial-to-mesenchymal transition and
cancer stem cell-like properties in aldehyde
dehydroghenase-negative thyroid cancer cells. Thyroid. 23:989–996.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou W, Lv R, Qi W, Wu D, Xu Y, Liu W, Mou
Y and Wang L: Snail contributes to the maintenance of stem
cell-like phenotype cells in human pancreatic cancer. PLoS One.
9:e874092014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu S, Kumar SM, Martin JS, Yang R and Xu
X: Snail1 mediates hypoxia-induced melanoma progression. Am J
Pathol. 179:3020–3031. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang W, Wang J, Zou B, Sardet C, Li J,
Lam CS, Ng L, Pang R, Hung IF, Tan VP, et al: Four and a half LIM
protein 2 (FHL2) negatively regulates the transcription of
E-cadherin through interaction with Snail1. Eur J Cancer.
47:121–130. 2011. View Article : Google Scholar
|
|
30
|
Zhang JP, Zeng C, Xu L, Gong J, Fang JH
and Zhuang SM: MicroRNA-148a suppresses the epithelial-mesenchymal
transition and metastasis of hepatoma cells by targeting Met/Snail
signaling. Oncogene. 33:4069–4076. 2014. View Article : Google Scholar
|
|
31
|
Merikallio H, Turpeenniemi-Hujanen T,
Pääkkö P, Mäkitaro R, Riitta K, Salo S, Salo T, Harju T and Soini
Y: Snail promotes an invasive phenotype in lung carcinoma. Respir
Res. 13:1042012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu H, Zhou L, Shi S, Wang Y, Ni X, Xiao
F, Wang S, Li P and Ding K: Oligosaccharide G19 inhibits U-87 MG
human glioma cells growth in vitro and in vivo by targeting
epidermal growth factor (EGF) and activating p53/p21 signaling.
Glycobiology. 24:748–765. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu Z, Zhang D, Hao J, Tian K, Wang W, Lou
H and Yuan H: Induction of DNA damage and p21-dependent senescence
by Riccardin D is a novel mechanism contributing to its growth
suppression in prostate cancer cells in vitro and in vivo. Cancer
Chemother Pharmacol. 73:397–407. 2014. View Article : Google Scholar
|
|
34
|
Rousseau D, Cannella D, Boulaire J,
Fitzgerald P, Fotedar A and Fotedar R: Growth inhibition by
CDK-cyclin and PCNA binding domains of p21 occurs by distinct
mechanisms and is regulated by ubiquitin-proteasome pathway.
Oncogene. 18:3290–3302. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao H, Ho PC, Lo YH, Espejo A, Bedford
MT, Hung MC and Wang SC: Interaction of proliferation cell nuclear
antigen (PCNA) with c-Abl in cell proliferation and response to DNA
damages in breast cancer. PLoS One. 7:e294162012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yanagawa J, Walser TC, Zhu LX, Hong L,
Fishbein MC, Mah V, Chia D, Goodglick L, Elashoff DA, Luo J, et al:
Snail promotes CXCR2 ligand-dependent tumor progression in
non-small cell lung carcinoma. Clin Cancer Res. 15:6820–6829. 2009.
View Article : Google Scholar : PubMed/NCBI
|
